These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23945136)

  • 1. Expression of neuroepithelial transforming gene 1 is enhanced in oesophageal cancer and mediates an invasive tumour cell phenotype.
    Lahiff C; Cotter E; Casey R; Doran P; Pidgeon G; Reynolds J; Macmathuna P; Murray D
    J Exp Clin Cancer Res; 2013 Aug; 32(1):55. PubMed ID: 23945136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer.
    Bennett G; Sadlier D; Doran PP; Macmathuna P; Murray DW
    BMC Cancer; 2011 Feb; 11():50. PubMed ID: 21284875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.
    Murray D; Horgan G; Macmathuna P; Doran P
    Br J Cancer; 2008 Oct; 99(8):1322-9. PubMed ID: 18827818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.
    Fisher OM; Levert-Mignon AJ; Lord SJ; Lee-Ng KK; Botelho NK; Falkenback D; Thomas ML; Bobryshev YV; Whiteman DC; Brown DA; Breit SN; Lord RV
    Br J Cancer; 2015 Apr; 112(8):1384-91. PubMed ID: 25867265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.
    Jiménez P; Piazuelo E; Cebrian C; Ortego J; Strunk M; García-Gonzalez MA; Santander S; Alcedo J; Lanas A
    Aliment Pharmacol Ther; 2010 Feb; 31(3):440-51. PubMed ID: 19843025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion.
    Byrne AM; Bekiaris S; Duggan G; Prichard D; Kirca M; Finn S; Reynolds JV; Kelleher D; Long A
    Br J Cancer; 2015 Nov; 113(9):1332-42. PubMed ID: 26461057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
    Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
    Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell lines.
    Onwuegbusi BA; Rees JR; Lao-Sirieix P; Fitzgerald RC
    PLoS One; 2007 Jan; 2(1):e177. PubMed ID: 17264880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
    Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S
    Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.
    Rogerson C; Ogden S; Britton E; ; Ang Y; Sharrocks AD
    Elife; 2020 Sep; 9():. PubMed ID: 32880368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
    Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
    Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma can modulate micronucleus frequency in TK6 and OE33 cells in vitro.
    Naser H; Munn K; Lawrence R; Wright R; Grewal E; Williams L; Doak S; Jenkins G
    Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503766. PubMed ID: 38821668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
    Melo AM; O'Brien AM; Phelan JJ; Kennedy SA; Wood NAW; Veerapen N; Besra GS; Clarke NE; Foley EK; Ravi A; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; Conroy MJ; Hogan AE; O'Sullivan J; Dunne MR
    Front Immunol; 2019; 10():1580. PubMed ID: 31354725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
    Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
    Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
    Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation.
    Beales IL; Ogunwobi OO
    J Mol Endocrinol; 2009 Apr; 42(4):305-18. PubMed ID: 19153190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
    Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
    Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
    Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
    Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.